Cancer Risk Data by Gender

The following data presents the risk factors associated with the development and mortality of different types of cancer among males and females, as reported by the American Cancer Society.
The provided statistics indicate both the percentage of individuals at risk of developing cancer and the likelihood of dying from it, as well as the odds expressed as a ratio (e.g., 1 in X).

Any cancer: 40.9% (1 in 2)
Bladder (includes in situ): 3.86% (1 in 26)
Brain and nervous system: 0.7% (1 in 147)
Breast: 0.1% (1 in 727)
Colon and rectum: 4.3% (1 in 23)
Esophagus: 0.80% (1 in 128)
Hodgkin lymphoma: 0.2% (1 in 435)
Kidney and renal pelvis: 2.3% (1 in 44)
Larynx (voice box): 0.5% (1 in 200)
Leukemia: 1.8% (1 in 55)
Liver and bile duct: 1.5% (1 in 66)
Lung and bronchus: 6.2% (1 in 16)
Melanoma of the skin: 3.5% (1 in 28)
Multiple myeloma: 0.9% (1 in 106)
Non-Hodgkin lymphoma: 2.3% (1 in 43)
Oral cavity and pharynx: 1.7% (1 in 60)
Pancreas: 1.7% (1 in 59)
Prostate: 12.6% (1 in 8)
Stomach: 1.0% (1 in 102)
Testicles: 0.40% (1 in 250)
Thyroid: 0.6% (1 in 155)

Any cancer: 20.2% (1 in 5)
Bladder (includes in situ): 0.9% (1 in 111)
Brain and nervous system: 0.5% (1 in 189)
Breast: < 0.1% (1 in 3,312)
Colon and rectum: 1.7% (1 in 58)
Esophagus: 0.7% (1 in 138)
Hodgkin lymphoma: < 0.1% (1 in 2,899)
Kidney and renal pelvis: 0.60% (1 in 167)
Larynx (voice box): 0.2% (1 in 570)
Leukemia: 0.9% (1 in 108)
Liver and bile duct: 1.0% (1 in 96)
Lung and bronchus: 4.7% (1 in 21)
Melanoma of the skin: 0.4% (1 in 240)
Multiple myeloma: 0.5% (1 in 219)
Non-Hodgkin lymphoma: 0.8% (1 in 128)
Oral cavity and pharynx: 0.4% (1 in 240)
Pancreas: 1.4% (1 in 71)
Prostate: 2.4% (1 in 41)
Stomach: 0.4% (1 in 246)
Testicles: < 0.1% (1 in 4,966)
Thyroid: 0.1% (1 in 1,706)

Any cancer: 39.1% (1 in 3)
Bladder (includes in situ): 1.1% (1 in 91)
Brain and nervous system: 0.5% (1 in 188)
Breast: 12.9% (1 in 8)
Cervix: 0.7% (1 in 153)
Colon and rectum: 3.9% (1 in 26)
Esophagus: 0.2% (1 in 439)
Hodgkin lymphoma: 0.2% (1 in 500)
Kidney and renal pelvis: 1.3% (1 in 75)
Larynx (voice box): 0.1% (1 in 852)
Leukemia: 1.3% (1 in 78)
Liver and bile duct: 0.7% (1 in 146)
Lung and bronchus: 5.8% (1 in 17)
Melanoma of the skin: 2.4% (1 in 41)
Multiple myeloma: 0.7% (1 in 134)
Non-Hodgkin lymphoma: 1.9% (1 in 53)
Oral cavity and pharynx: 0.7% (1 in 141)
Ovary: 1.1% (1 in 88)
Pancreas: 1.6% (1 in 61)
Stomach: 0.6% (1 in 157)
Thyroid: 1.7% (1 in 59)
Uterus: 3.1% (1 in 33)

Any cancer: 17.7% (1 in 5)
Bladder (includes in situ): 0.3% (1 in 294)
Brain and nervous system: 0.4% (1 in 241)
Breast: 2.5% (1 in 39)
Cervix: 0.2% (1 in 466)
Colon and rectum: 1.6% (1 in 63)
Esophagus: 0.20% (1 in 524)
Hodgkin lymphoma: < 0.1% (1 in 3,819)
Kidney and renal pelvis: 0.3% (1 in 316)
Larynx (voice box): < 0.1% (1 in 2,346)
Leukemia: 0.7% (1 in 152)
Liver and bile duct: 0.6% (1 in 181)
Lung and bronchus: 4.0% (1 in 25)
Melanoma of the skin: 0.2% (1 in 465)
Multiple myeloma: 0.4% (1 in 275)
Non-Hodgkin lymphoma: 0.6% (1 in 167)
Oral cavity and pharynx: 0.2% (1 in 537)
Ovary: 0.8% (1 in 123)
Pancreas: 1.4% (1 in 73)
Stomach: 0.30% (1 in 333)
Thyroid: 0.1% (1 in 1,440)
Uterus: 0.7% (1 in 152)

American Cancer Society. Lifetime risk of developing or dying from cancer. Available online at: http://www.cancer.org/canc